MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary

Abstract excerpt

Metastasis is responsible for the majority of cancer-related deaths. Particularly, challenging is the management of metastatic cancer of unknown primary site (CUP), whose tissue of origin (TOO) remains undetermined even after extensive investigations and whose therapy is rather unspecific and poorly effective. Molecular approaches to identify the most probable TOO of CUPs can overcome some of these issues. In...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Diagnosis and Treatment
• Share to Oral and Maxillofacial Pathology
• Share to Tumors and Oncological Cases